Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | SVP, Corp. Controller & CAO | March 04, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,196 |
Ending reported balance
After 2026-03-04 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-04 · Grant · Acquired 1,473 · Balance 35,946 F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Row 2 · 2026-03-04 · Tax withholding · Disposed 750 · Balance 35,196 F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2022 Filed Feb 26, 2022 00:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 94 | $130.23 | $12,241.62 |
DisclosureSEC source: 0001022079-22-000019 · wf-form4_164583422190891.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,727 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. F2 · balance_after: The amount includes approximately 169 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 00:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 219 | $130.09 | $28,489.71 |
DisclosureSEC source: 0001022079-22-000019 · wf-form4_164583422190891.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,640 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 5 | $136.60 | $683.00 |
DisclosureSEC source: 0001022079-21-000079 · wf-form4_162154236496004.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,859 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. F3 · balance_after: The amount includes approximately 59 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 684 | $115.42 | $78,947.28 |
DisclosureSEC source: 0001022079-21-000056 · wf-form4_161549814943604.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,802 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 09, 2021 Filed Mar 11, 2021 21:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,884 | $115.42 | $217,451.28 |
DisclosureSEC source: 0001022079-21-000056 · wf-form4_161549814943604.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,485 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 19, 2018, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 103 | $121.19 | $12,482.57 |
DisclosureSEC source: 0001022079-21-000042 · wf-form4_161428895318755.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,601 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 21:36 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 159 | $121.15 | $19,262.85 |
DisclosureSEC source: 0001022079-21-000042 · wf-form4_161428895318755.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,704 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of previous grants of restricted shares. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 4,003 | $0.00 Strike: $121.81 | $0.00 |
DisclosureSEC source: 0001022079-21-000021 · wf-form4_161378529998296.xml · derivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,003 Underlying: Common Stock · 4,003 shares Expires 2031-02-17 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 01:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 715 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000021 · wf-form4_161378529998296.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,863 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. F3 · balance_after: The amount includes approximately 53 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,700 | $57.61 Strike: $57.61 | $328,348.50 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · derivative · entry 7 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,700 shares Expires 2022-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020. F6 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 4,750 | $56.82 Strike: $56.82 | $269,895.00 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · derivative · entry 6 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,750 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 15, 2012, the second on February 15, 2013 and the final on February 15, 2014. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 4,750 | $125.00 | $593,750.00 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · nonDerivative · entry 4 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,090 F2 · balance_after: The amount includes approximately 46 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,700 | $125.00 | $712,500.00 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · nonDerivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,785 Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 5,700 | $57.61 | $328,348.50 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020. Read SEC document |
| October 21, 2020 Filed Oct 23, 2020 20:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 4,750 | $56.82 | $269,895.00 |
DisclosureSEC source: 0001022079-20-000186 · wf-form4_160348572710096.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2020. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 5 | $107.42 | $537.10 |
DisclosureSEC source: 0001022079-20-000109 · wf-form4_159000678717251.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,035 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. F2 · balance_after: The amount includes approximately 59 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:54 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 277 | $106.46 | $29,489.42 |
DisclosureSEC source: 0001022079-20-000069 · wf-form4_158404643426730.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,977 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. F3 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:54 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 837 | $106.46 | $89,107.02 |
DisclosureSEC source: 0001022079-20-000069 · wf-form4_158404643426730.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,253 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2017, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 00:17 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 98 | $112.90 | $11,064.20 |
DisclosureSEC source: 0001022079-20-000051 · wf-form4_158284902657071.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,416 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted shares. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 49 | $113.34 | $5,553.66 |
DisclosureSEC source: 0001022079-20-000049 · wf-form4_158275292932701.xml · nonDerivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,514 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 56 | $112.17 | $6,281.52 |
DisclosureSEC source: 0001022079-20-000049 · wf-form4_158275292932701.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,563 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 5,059 | $0.00 Strike: $112.17 | $0.00 |
DisclosureSEC source: 0001022079-20-000033 · wf-form4_158224919624407.xml · derivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,059 Underlying: Common Stock · 5,059 shares Expires 2030-02-18 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 776 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000033 · wf-form4_158224919624407.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,619 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. F3 · balance_after: The amount includes approximately 103 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 20:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 5,000 | $55.65 Strike: $55.65 | $278,250.00 |
DisclosureSEC source: 0001022079-19-000168 · wf-form4_156892493506700.xml · derivative · entry 4 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 29, 2019. F5 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 10, 2011, the second on February 10, 2012 and the final on February 10, 2013. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 20:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,000 | $106.00 | $530,000.00 |
DisclosureSEC source: 0001022079-19-000168 · wf-form4_156892493506700.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,732 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 29, 2019. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. F3 · balance_after: The amount includes approximately 53 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 20:29 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 5,000 | $55.65 | $278,250.00 |
DisclosureSEC source: 0001022079-19-000168 · wf-form4_156892493506700.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on July 29, 2019. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 608 | $0.00 Strike: $97.28 | $0.00 |
DisclosureSEC source: 0001022079-19-000124 · wf-form4_155795240817276.xml · derivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608 Underlying: Common Stock · 608 shares Expires 2029-02-18 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000124 · wf-form4_155795240817276.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,671 F1 · shares: Represents an award of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. F3 · balance_after: The amount includes approximately 59 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.